Arrayit Corporation (ARYC)

[MikeCr]

From the presenting companies at the SCIA investor conference, you left out Provectus Pharmaceuticals (PVCT) one of the 6 companies that presented along with ARYC.

Dr. Craig Dees's the CEO made a compelling technical presentation of the two drugs PVCT is developing:

PV-10, which utilizes a dye called Rose Bengal to selectively target and kill cancer cells. Currently, the drug is preparing to begin Phase III trials for metastatic Melanoma, after showing promise in its Phase II trial results. The drug is also effective against liver and breast cancer and possibly others. The drug is being made available to severe patients through the FDA’s Compassionate Use Program. Since the drug has been used as a staining dye to find scratches in the eye for years, regulators view it as being relatively low-risk. They also presented at ASCO. They have worked on this drug for 8 years and spent only $78 million, compared to Dendreon that spent $1.5 billion and took 12 years to develop its drug.

PH-10 to treat severe psoriasis (clinical trials currently under way) and atopic dermatitis (clinical trials currently under way)

Provectus SCIA presentation:

http://www.sciaconference.com/PublicCo/June2010/PVCT/Index.html

Based on this info I took a small position in PVCT to test the waters.

Not too many messages in Ihub message board for PVCT. But there is a lot of buzz at the "Silicon Investor" Message board which Ihub took over recently and has the same "look and feel" as Ihub. ARYC is not in Silicon Investor yet, don't know why.

http://siliconinvestor.advfn.com/subject.aspx?subjectid=56560